Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovims vectors

Nature Medicine

Volumn 2, Issue 5, 1996, Pages 545-550

  Tripathy, Sandeep K ^a   Black, Hugh B ^a   Goldwasser, Eugene ^a   Leiden, Jeffrey M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT GENE;

ADENOVIRIDAE; ADENOVIRUS E1 PROTEINS; ADENOVIRUS E3 PROTEINS; ANIMALS; BASE SEQUENCE; ERYTHROPOIETIN; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS, INTRAMUSCULAR; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; TRANSGENES;

EID: 0029936764     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0596-545     Document Type: Article

References (30)

1. Kozarsky, K.F. & Wilson, J.M. Gene therapy: Adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503 (1993).
2. Kremer, E.J. & Perricaudet, M. Adenovirus and adeno-associated virus mediated gene transfer. Br. Med. Bull. 51, 31-44 (1995).
3. Brody, S.L. & Crystal, R.G. Adenovirus-mediated in vivo gene transfer. Ann. N.Y. Acad. Sci. 716, 90-101 (1994).
4. Dai, Y. et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405 (1995).
5. Smith, T.A.G. et al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5, 397-402 (1993).
6. Kozarsky, K.F. et al. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269, 13695-13702 (1994).
7. Quantin, B., Perricaudet, L.D., Tajbakhsh, J. & Mandel, J. Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA 89, 2581-2584 (1992).
8. Rosenfeld, M.A. et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155 (1992).
9. Barr, E. et al. Percutaneous transluminal gene transfer into the heart using replication-defective recombinant adenovirus. Gene Ther. 1, 51-58 (1994).
10. Yang, Y., Ertl. J. & Wilson J.M. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442 (1994).
11. Yang, Y., Li, Q., Ertl, H.C. & Wilson, J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411 (1994).
12. Yang, Y. et al. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015 (1995).
13. Tripathy, S.K. et al. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA 91, 11557-11561 (1994).
14. McDonald, J.D., Lin, F.K. & Goldwasser, E. Cloning, sequencing, and evolutionary analysis of the mouse erythropoietin gene. Mol. Cell. Biol. 6, 842-848 (1986).
15. Rawle F.C. et al. Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5: E1A is immunodominant in H-2b, but not in H-2d or H-2k mice. J. Immun. 146, 3977-3984 (1991).
16. Barr, D. et al. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151-155 (1995).
17. + T cells. Science 248, 1227-1230 (1990).
18. Zinkernagel, R.M. et al. Virus-induced autoantibody response to a transgenic viral antigen. Nature 345, 68-71 (1990).
19. Ohashi, P.S. et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65, 305-317 (1991).
20. Weigle, W.O. Termination of acquired immunological tolerance to protein antigens following immunization with altered protein antigens. J. Exp. Med. 116, 913-928 (1962).
21. Mamula, M.J, Lin, R.H., Janeway, C.J. & Hardin, J.A. Breaking T cell tolerance with foreign and self co-immunogens: A study of autoimmune B and T cell epitopes of cytochrome c. J. Immun. 149, 789-795 (1992).
22. Lin, R.H., Mamula, M.J., Hardin, J.A. & Janeway, C.J. Induction of autoreactive B cells allows priming of autoreactive T cells. J. Exp. Med. 173, 1433-1439 (1991).
23. Engelhardt, J.F. et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Biological efficacy study. Hum. Gene Ther. 4, 759-769 (1993).
24. Engelhardt, J.F. et al. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nature Genet. 4, 27-34 (1993).
25. Simon, R.H. et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum. Gene Ther. 4, 771-780 (1993).
26. Engelhardt, J.F., Ye, X., Doranz, B. & Wilson, J.M. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200 (1994).
27. Engelhardt, J.F., Litzky, L. & Wilson, J.M. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum. Gene Ther. 5, 1217-1229 (1994).
28. Yang, Y. et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369 (1994).
29. Kay, M. et al. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nature Genet. 11, 191-196 (1995).
30. Goldwasser, E. & Sherwood, J.B. Radioimmunoassay of erythropoietin. Br. J. Haematol. 48, 359-363 (1981).